IL-17 Activators

Interleukin-17 (IL-17) is a pro-inflammatory cytokine produced primarily by T helper 17 (Th17) cells, as well as other immune cells such as γδ T cells, natural killer T cells, and certain subsets of innate lymphoid cells. IL-17 plays a central role in immune responses against extracellular pathogens, particularly fungi and bacteria, and is involved in the pathogenesis of various autoimmune and inflammatory diseases. The functions of IL-17 are diverse and include the recruitment and activation of neutrophils, induction of pro-inflammatory cytokines and chemokines, regulation of tissue inflammation and remodeling, and enhancement of antimicrobial responses at mucosal surfaces. Moreover, IL-17 promotes the development of tertiary lymphoid structures and the maintenance of tissue homeostasis under conditions of chronic inflammation. Dysregulated IL-17 signaling is implicated in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis, highlighting its importance in immune regulation and disease pathophysiology.

Activation of IL-17 signaling occurs through complex mechanisms involving both innate and adaptive immune responses. The differentiation of naïve CD4+ T cells into Th17 cells, mediated by specific cytokines such as transforming growth factor-beta (TGF-β), interleukin-6 (IL-6), interleukin-23 (IL-23), and interleukin-1β (IL-1β), is a crucial step in IL-17 activation. These cytokines promote the expression of the master transcription factor retinoic acid receptor-related orphan receptor gamma t (RORγt), which drives the production of IL-17 and other Th17-associated cytokines. Additionally, IL-17 signaling is regulated by various signaling pathways, including nuclear factor-kappa B (NF-κB), mitogen-activated protein kinases (MAPKs), and signal transducer and activator of transcription 3 (STAT3), which mediate the transcriptional activation of IL-17-responsive genes. Furthermore, IL-17 can synergize with other pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) to amplify immune responses and promote tissue inflammation. Overall, understanding the mechanisms of IL-17 activation provides insights into its role in immune regulation and disease pathogenesis, offering targets for intervention in immune-mediated disorders.